ClC-5: role in endocytosis in the proximal tubule by Wang, Yinghong et al.
ClC-5: role in endocytosis in the proximal tubule
Yinghong Wang,1 Hui Cai,1,2 Liudmila Cebotaru,1 Deanne H. Hryciw,1 Edward J. Weinman,3
Mark Donowitz,1,2 Sandra E. Guggino,1,2 and William B. Guggino1
Departments of 1Physiology and 2Medicine, Johns Hopkins University, Baltimore; and 3Department
of Medicine, University of Maryland School of Medicine, Baltimore, Maryland
Submitted 14 January 2005; accepted in final form 28 May 2005
Wang, Yinghong, Hui Cai, Liudmila Cebotaru, Deanne H.
Hryciw, Edward J. Weinman, Mark Donowitz, Sandra E. Gug-
gino, and William B. Guggino. ClC-5: role in endocytosis in the
proximal tubule. Am J Physiol Renal Physiol 289: F850–F862, 2005.
First published June 7, 2005; doi:10.1152/ajprenal.00011.2005.—The
proper functioning of the Cl channel, ClC-5, is essential for the
uptake of low molecular mass proteins through receptor-mediated
endocytosis in the proximal tubule. Dent’s disease patients with
mutant ClC-5 channels and ClC-5 knockout (KO) mice both have low
molecular mass proteinuria. To further understand the function of
ClC-5, endocytosis was studied in LLC-PK1 cells and primary cul-
tures of proximal tubule cells from wild-type (WT) and ClC-5 KO
kidneys. Endocytosis in the proximal tubule cells from KO mice was
reduced compared with that in WT animals. Endocytosis in WT but
not in KO cells was inhibited by bafilomycin A-1 and Cl depletion,
whereas endocytosis in both WT and KO cells was inhibited by the
NHE3 blocker, S3226. Infection with adenovirus containing WT
ClC-5 rescued receptor-mediated endocytosis in KO cells, whereas
infection with any of the three disease-causing mutants, myc-W22G-
ClC-5, myc-S520P-ClC-5, or myc-R704X-ClC-5, did not. WT and the
three mutants all trafficked to the apical surface, as assessed by
surface biotinylation. WT-ClC-5 and the W22G mutant were inter-
nalized similarly, whereas neither the S520P nor the R704X mutants
was. These data indicate that ClC-5 is important for Cl and proton
pump-mediated endocytosis. However, not all receptor-mediated en-
docytosis in the proximal tubule is dependent on ClC-5. There is a
significant fraction that can be inhibited by an NHE3 blocker. Our
data from the mutants suggest that defective targeting and trafficking
of mutant ClC-5 to the endosomes are a major determinant in the lack
of normal endocytosis in Dent’s disease.
knockout mice; albumin; dextran; Na-H exchanger type 3; bafilomy-
cin A-1; gluconate; adenovirus
EPITHELIAL CELLS OF THE RENAL proximal tubule have a high
capacity for endocytosis of a broad range of extracellular
proteins (29). The renal glomerular membrane retains cells and
large proteins within the blood, whereas small proteins pass
into the primary urine and are subsequently removed by recep-
tor-mediated endocytosis at the brush-border membrane of the
proximal tubules (27). As in every eukaryotic cell, endocytic
vesicles in proximal tubular epithelial cells are progressively
acidified (31). Dissipation of the intravesicular pH gradients
inhibits the overall process of endocytosis (7). A Cl channel,
ClC-5, is expressed in the renal proximal tubule, the thick
ascending limb, and the intercalated cells of the collecting duct
(12). It is abundant in renal proximal tubular subapical endo-
somes where it colocalizes with the V type H-ATPase (20,
34). This suggests that ClC-5 may be involved in proximal
tubular endocytosis by providing an electrical shunt that is
necessary for the efficient acidification of vesicles in the
endocytic pathway by neutralizing the positive charges pro-
duced by the H-ATPase.
Studies have shown that ClC-5 may have a role in endocy-
tosis in addition to acting as a Cl shunt. We found previously
that the COOH-terminal tail of ClC-5 binds to the actin
depolymerizing protein, cofilin (23). Cofilin is an ubiquitously
expressed member of the cofilin/ADF family of actin-associ-
ated proteins that binds to both filamentous (F-actin) and
monomeric (G-actin) actin to stimulate depolymerization of the
actin microfilaments (2). Phosphorylation of cofilin in two
proximal tubule cell models [LLC-PK1 and opossum kidney
(OK)] is also accompanied by a pronounced inhibition of
albumin uptake. We proposed that the interaction of cofilin
with ClC-5 at the plasma membrane plays a crucial role in
mediating actin depolymerization, leading to a highly localized
dissolution of the terminal actin web and facilitating budding
of the endosome from the plasma membrane. In another study,
the COOH-terminal tail of ClC-5 was shown to interact with
the ubiquitin ligases Nedd4/Nedd4–2 (22). This study also
showed that Nedd4–2 is a physiological regulator of constitu-
tive albumin uptake. The results suggested that in response to
the increased endocytosis, cells produce more ClC-5 and
Nedd4–2 thereby increasing membrane turnover/endocytosis,
proteosomal activity, and resultant degradation of albumin.
These two studies suggested that in addition to its role as a
shunt pathway for Cl, ClC-5 may function as a structural
component of the endocytic apparatus important both in bud-
ding of the endosome and in the processing of its cargo.
Dent’s disease is an X-chromosome-linked disorder charac-
terized by low molecular mass proteinuria, aminoaciduria,
glycosuria, and hypercalciuria, which leads to nephrocalcino-
sis, nephrolithiasis, and progressive renal failure (14). These
patients have abnormal proximal tubule endocytosis of albu-
min and vitamin D-binding protein, which is caused by muta-
tions in the gene encoding ClC-5, predominantly expressed in
the kidney (25, 37). There are many single amino acid muta-
tions in ClC-5, which can cause Dent’s disease with similar
symptoms (26). The physiological properties of some of these
mutants have been studied in Xenopus laevis oocytes and some
basic properties have been characterized (25, 26, 37).
Defects in the ability of ClC-5 to act as a shunt pathway for
Cl and subsequent disruption of endocytosis have been sug-
gested as the explanation of the low molecular mass proteinuria
observed in Dent’s patients (12, 33). In addition, it has been
shown that the brush-border components megalin and cubilin
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are dramatically reduced in knockout (KO) mice (6, 33).
Defects in the trafficking of megalin and cubilin in the proxi-
mal tubule would also significantly impair the uptake of low
molecular mass proteins into the body.
Studies with the ClC-5 KO mouse model show impaired
endocytosis in the proximal tubules, which results in low
molecular mass proteinuria, aminoaciduria, and glycosuria as
occurs in Dent’s disease (33, 38). To understand the role of
ClC-5 in the endocytic process, we studied both LLC-PK1
cells, in which ClC-5 is expressed abundantly thereby allowing
detailed biochemical studies, as well as primary renal proximal
tubule cells derived from normal and KO mice. In addition, to
further elucidate the mechanism of three different ClC-5 mu-
tations found in human patients, we studied their expression,
trafficking, and endocytic function in transfected LLC-PK1
cells and infected primary renal tubule cells. Our data show
that ClC-5 is important for Cl and proton pump-mediated
endocytosis. Importantly, not all receptor-mediated endocyto-
sis in the proximal tubule is dependent on ClC-5, with a
significant fraction dependent on NHE3. Our data from the
mutants suggest that defective targeting and trafficking to the
endosomes of some of the mutant forms of ClC-5 are a major
determinant in the lack of normal endocytosis in Dent’s dis-
ease.
EXPERIMENTAL PROCEDURES
Plasmids and constructs. Wild-type (WT) human ClC-5 was am-
plified by PCR using a human kidney cDNA library from Incyte
(Wilmington, DE) as the template. PCR primers were based on the
human ClC-5 sequence (GenBank accession no. NM_000084). An
NH2-terminal myc tagged ClC-5 construct was generated by subclon-
ing ClC-5 cDNA into a pCMV-myc vector (Clontech, Palo Alto, CA)
using EcoRI and KpnI sites. ClC-5 mutants W22G, S520P, and
R704X were generated using a myc-tagged WT ClC-5 construct as a
template using the Quickchange Site-Directed Mutagenesis Kit (Strat-
agene, La Jolla, CA). Myc-tagged WT and three mutant ClC-5 cDNAs
were subcloned into pAd/CMV/V5-DEST vectors (Invitrogen, Carls-
bad, CA) to generate adenovirus containing ClC-5. All constructs
were confirmed by DNA sequencing.
Cell culture, transfection, and infection. A pig renal proximal
tubule cell line (LLC-PK1) was obtained from American Type Culture
Collection (Manassas, VA). LLC-PK1 cells were maintained in
DMEM/F-12 supplemented with 10% fetal bovine serum, 50 U/ml
penicillin, and 10 ng/ml streptomycin. Cells were all grown on
Transwell inserts (Fisher, Newark, DE) with a pore size of 0.4 m and
were studied 1 day postconfluency after 2 wk except some samples
for Western blot analysis, in which case the cells were grown on
dishes. Cells were transfected using LipofectAmine 2000 (Invitrogen)
according to the manufacturer’s instructions and studied 24 h post-
transfection
The protocol for extracting primary proximal tubule cells from WT
and ClC-5 KO mice kidneys (confirmed by genomic PCR) was
modified from a previous study (9). Each time, three 2- to 4-mo-old
mice were anesthetized, and six kidneys were removed and transferred
to cold PBS. After decapsulation, the cortex was collected and minced
and exposed to 1% collagenase type II (Worthington, Lakewood, NJ)
and 0.25% soybean trypsin inhibitor (Invitrogen) to allow digestion
for 30 min at 37°C. This digestion procedure was repeated once. On
completion, the pellet collected was resuspended in 35 ml of 45%
Percoll solution and centrifuged at 26,891 g for 40 min. The highly
enriched population of proximal tubules and isolated single proximal
tubule cells that sedimented right above the red cell layer was washed
to remove the Percoll, plated on Transwell inserts, and fed with a
defined medium (DMEM/F-12 Ham’s 1:1, 0.015 M NaHCO3, pH 7.4,
0.1 mM Na pyruvate, 2.5 mM NaCl, 50 g/ml human transferrin, 50
nM sodium selenate, 2 mM L-glutamine, 5 108 M dexamethasone,
0.87 M bovine insulin, 20 mM HEPES, 10 ng/ml epidermal growth
factor, 50 M prostaglandin E1, 5 pM 3,3,5-triiodo-L-thryronine, 50
U/ml penicillin, 10 ng/ml streptomycin). Medullary collecting duct
cells (MCDC) were collected as described (24) and fed with the same
defined medium as above. The identity of medullary origin of these
cells was confirmed by staining with lectin from Dolichos biflorus
(DBA; Vector Labs, Burlingame, CA) (not shown) (24, 36). The
primary cells were used when they became confluent, usually about 2
wk. Primary proximal tubule cells were infected with adenovirus at a
multiplicity of infection (MOI) of 250 in the culture medium 48 h
before the studies.
Antibodies and immunofluorescent staining. Mouse monoclonal
antibody (9E10) for c-myc was obtained from Santa Cruz Biotech-
nology (Santa Cruz, CA). Rabbit polyclonal and mouse monoclonal
antibodies for ZO-1 were from Zymed Laboratory (South San Fran-
cisco, CA). Rabbit anti-AQP-1 antibody was from Alpha Diagnostic
(San Antonia, TX). FITC-albumin and FITC-dextran (molecular mass
40,000) were obtained from Sigma (St. Louis, MO). Rabbit antibodies
for aminopeptidase N (38), megalin (459) (10), and ClC-5 (38) were
generously provided by Dr. A. Hubbard (Johns Hopkins University),
Dr. R. Orlando (UCSD), and Dr. O. Devuyst (Universite´ Catholique
de Louvain), respectively. Fluorescent-labeled secondary antibodies
were from Jackson Immunoresearch Lab (West Grove, PA). For
immunostaining, cells were fixed with 4% paraformaldehyde at room
temperature for 15 min, permeabilized with 0.1% Triton X-100 for
1–2 min, and blocked with 3% nonfat milk in PBS for 30 min. The
cells were incubated with primary antibody in the blocking solution
for 30 min to 1 h, washed with PBS three times, and incubated with
secondary antibody for 1 h. Then, the cells were washed thoroughly
and mounted in Vectashield medium (Vector Lab). Finally, the slides
were sealed with cytoseal 60 (Richard-Allan Scientific, Kalamazoo,
MI) and viewed with an Ultraview confocal microscope (PerkinElmer
Life Sciences, Boston, MA) fitted with a63 oil immersion objective
lens (Zeiss Plan-Apochromat). In all the immunofluorescent experi-
ments, negative controls were performed by staining the cells with the
secondary antibody only or without transfection. For the double-
labeling experiments, specimens stained with a single label were
examined under the other fluorescent channel to determine bleed-
through. The intensity of both dyes in the double-stained specimens
was balanced to reduce artifacts.
Endocytosis assay. Ringer solution, pH 7.4 (140 mM NaCl, 2.7
mM KCl, 1.8 mM CaCl2, 1 mM MgCl2, 12.4 mM HEPES, and 5 mM
glucose), was used for all assays. For low-Cl solutions, NaCl was
replaced with equimolar sodium gluconate or NaBr. The NHE3
blocker S3226 (1 M) was made in Ringer solution. LLC-PK1 cells
were plated on Transwell inserts in regular medium for 3–5 days to
ensure that the cells were polarized before the experiments. Before
endocytosis assays, the cells were incubated in the solutions contain-
ing chloride, gluconate, or bromide at 37°C for 30 min. Next, the cells
were exposed to prewarmed fluorescent-labeled endocytic markers, as
described below, from their apical surfaces at 37°C for 0, 1, 2, 5, 10,
15, and 30 min. After the incubation, the cells were put on ice and
washed with ice-cold PBS eight times to stop the endocytic process.
The residual fluorescent markers on the cell surface were removed
with acid-stripping buffer (50 mM glycine, 2 M urea, 30 g/l BSA, 100
mM NaCl, pH 2.5). Then, the cells were fixed and immunostaining
was performed according to the procedures described above with
specific mouse anti-ZO-1 primary antibody and cy3-anti-mouse sec-
ondary antibody. All the negative controls were done at 4°C.
The primary cells (both the WT and ClC-5 KO) were treated with
the same solutions as above at 37°C for 2 h, which was shown to have
the best effect from series of tests with different time points. Then, the
endocytosis assay was performed as above for LLC-PK1 cells except
that only the 15-min time point was used. Images of fluorescent-
labeled markers were acquired by a Zeiss Axiovert fluorescence
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microscope (Achrostigmat objective lens 40), and the average
intensity per cell was calculated using IPlab software from multiple
images after background subtraction. The endocytic curve consisting
of average total intensity per cell vs. time was plotted using Origin.
Pulse chase endocytosis assay in primary proximal tubular cells.
Primary tubular cells were incubated with fluorescent-labeled dextran
(5 or 50 mg/ml) for 1 or 5 min at 37°C, then the dextran was washed
away and the cells were incubated with prewarmed medium for 15 or
30 min. Then, cells were fixed and stained with anti-megalin or
anti-AQP-1 antibody. FITC-conjugated secondary antibody was used
for the detection of the primary antibody.
Western blot analysis. Cells were harvested in lysis buffer (60 mM
HEPES, pH 7.5, 150 mM NaCl, 3 mM KCl, 5 mM EDTA, 5 mM
EGTA, 1% Triton X-100, and complete protease inhibitor from Roche
Diagnostics, Indianapolis, IN) and syringe homogenized. Lysates
were centrifuged at 6,000 g for 10 min to remove the insoluble
fraction, and the supernatant protein was quantified using a Bio-Rad
Protein Assay Kit (Pierce, Rockford, IL). After incubation in Laemmli
Fig. 1. Primary cell culture of mouse proximal tubule
cells. A: bright-field images showing wild-type (WT)
primary cells cultured for 2 wk. Primary cells were
plated in either plastic dishes or Transwell inserts after
being collected by the protocol defined in EXPERIMENTAL
PROCEDURES. Left: image shows the dome formation.
Right: typical cobblestone morphology. WT and ClC-5
knockout (KO) cells had similar differentiated morphol-
ogy (bar 100 m for both images). B: immunostaining
with an antibody specific for a proximal tubule protein
aquaporin (AQP)-1 (green) confirmed the identity of the
primary cells (bar 20 m). C: Western blot of primary
cell lysate with anti-ClC-5 antibody showing a large
amount of expression of ClC-5 in lanes 4 and 5 (primary
proximal tubular cells grown in dishes and inserts,
respectively). Cos-7 lysate was a negative control (lane
1). LLC-PK1 cell (lane 2) and OK cell lysate (lane 3)
were used as positive controls. Each lane was loaded
with 50 g of protein. D: Western blot analysis of WT
and KO primary cells with anti-APN antibody further
confirming the identity of primary cells and the similar-
ity between these 2 preparations: lysates from WT (lane
1) and KO (lane 2) proximal tubules as positive con-
trols; LLC-PK1 (lane 3) cell lysate used as another
positive control; lanes 4 and 5 are lysates from WT and
KO primary collecting duct cells grown on dishes as
negative controls; lanes 6 and 7 are lysates from WT
and KO primary proximal tubular cells grown on plastic
dishes. Each lane was loaded with 40 g of protein. NS,
no significant difference in APN expression between
WT and KO cells, n  4. E: Western blot analysis of
primary cultured cells with anti-megalin antibody con-
firms the expression of megalin in WT (lane 5) and KO
(lane 6) primary cells. Lysates from WT (lane 1) and
KO (lane 2) proximal tubules and LLC-PK1 cells (lane
7) were used as positive controls. Lysates of medullary
collecting duct cells from WT (lane 3) and KO (lane 4)
animals and Cos-7 cells (lane 8) were used as negative
controls. Each lane was loaded with 20 g. *P  0.001
is the difference in megalin expression between WT and
KO cells, n  4.
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buffer (Bio-Rad, Hercules, CA) at 37°C for 30 min, the protein sample
was separated by SDS-PAGE and transferred to PVDF membranes
(Amersham Biosciences, Piscataway, NJ) for Western blot analysis.
After antibody labeling, detection was performed with ECL (Amer-
sham Biosciences, Piscataway) or Super Signal (Pierce) according to
instructions from the suppliers.
Surface biotinylation. Cell-surface biotinylation experiments were
performed on LLC-PK1 cells 1 day after transfection with myc-ClC-5
constructs. LLC-PK1 cells were incubated with 5 ml PBS with 0.8
mg/ml NHS-S-S-biotin (Pierce) at 4°C with rocking for 30 min. Then,
the free biotin in PBS was quenched with 100 mM glycine. Cells were
washed with ice-cold PBS three times before the collection of lysates.
Six-hundred micrograms of lysate protein were rocked with Neutra-
vidin-beads (Pierce) at 4°C overnight. Ten micrograms of lysate
protein were used to determine the total expression. The beads were
washed with lysis buffer and eluted into Laemmli sample buffer and
separated by SDS-PAGE for Western blot analysis using an anti-myc-
antibody. The images were acquired with Fuji film Image Reader
(LAS-1000 Lite), and quantification was done with ImageGauge 4.0.
The percentage of the protein on the surface compared with the total
cell lysate was calculated after the subtraction of background. Back-
ground was measured by exposing the beads to myc-ClC-5 lysate
without biotin exposure.
Internalization of surface biotinylated myc-ClC-5 in LLC-PK1
cells. LLC-PK1 cells were transfected with myc-ClC-5 1 day before
the assay. The cells were incubated with NHS-S-S-Biotin (Pierce) at
the apical surface at 4°C for 30 min to allow biotin binding. The free
biotin in the incubation solution was then quenched by adding 100
mM glycine solution. The cells were recovered to 37°C by incubation
with prewarmed medium for 30 min. After allowing endocytosis to
occur at 37°C, cells were put on ice and washed with ice-cold PBS to
stop the endocytosis. The biotin that was not internalized was cleaved
off by exposure to 150 mM glutathione (Sigma) for 30 min. The rest
of the procedure was the same as described in surface biotinylation.
The percentage of myc-ClC-5 that was internalized from the surface
was compared with the total ClC-5 in the lysate. The fraction of
internalized ClC-5 in the surface pool was quantified by comparing
the internalization and surface biotinylation assays. Background was
assessed again by exposing the beads to myc-ClC-5 lysate without the
surface biotinylation.
Statistical analysis. For statistical analysis, we used the Student’s
t-test to determine the statistical significance. The results are presented
as means 	 SE. A P value 0.05 was considered to be statistically
significant.
RESULTS
Primary cultures of proximal tubule cells. After 2 wk,
primary cultures from mouse kidneys were confluent with
dome formation in some areas. WT cells and ClC-5 KO cells
had similar differentiated cobblestone morphology (Fig. 1A).
Several lines of evidence confirmed that the primary cultures
retain characteristics consistent with their proximal tubule
origin. Immunostaining and biochemical studies confirmed that
the cells express AQP-1 (Fig. 1B), ClC-5 (Fig. 1C), APN (Fig.
1D), and megalin (Fig. 1E).
ClC-5 antibodies also detected the expression of ClC-5 in
cultured proximal tubule cells grown both on plastic dishes and
Transwell inserts. LLC-PK1 and OK cells were used as
positive controls because both have been shown to express
ClC-5 (23, 35), and Cos-7 cell lysate, a cell line shown to be
negative for ClC-5 expression (39), was used as a negative
control (Fig. 1C).
Because APN is a proximal tubule cell marker (38), for these
experiments, lysates from LLC-PK1 cells and proximal tubules
isolated from mouse kidneys were used as positive controls.
Fig. 2. Endocytosis of dextran in primary proximal tubule cells.
Endocytosis of RITC-dextran in the WT primary cells was
much greater than that in the KO primary cells. A: some vesicles
(red) were formed in the WT primary cells after pulse labeling
with dextran (5 mg/ml) for 1 min and chasing for 15 min at
37°C, whereas none was present in the ClC-5 KO cells. Megalin
staining is shown in green. B: with longer pulse labeling (5 min)
and chasing time (30 min), and a higher dextran concentration
(50 mg/ml), a small amount of endocytosis was detected in
ClC-5 KO cells, which was much less than that of the WT cells.
AQP-1 staining is in green.
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Fig. 3. Endocytosis assay with albu-
min and dextran in primary cells con-
firms the impairment of endocytic
function in the proximal tubule cells
of ClC-5 KO mice. A: endocytosis of
FITC-albumin was detected in proxi-
mal tubule cells (PTC) and medullary
collecting duct cells (MCDC). The
cells internalized FITC-albumin at
37°C for 15 min and then were
washed with ice-cold PBS to stop the
endocytosis. Compared with the up-
take in WT PTC, ClC-5 KO cells have
much less albumin endocytosis (Aa,
bar 20 m). Ab: endocytosis of
MCDC under the same conditions. No
noticeable difference in the endocyto-
sis of albumin was found between WT
and ClC-5 KO MCDC. B: negative
controls of the assay were done at
4°C. Ba: PTC. Bb: MCDC. ZO-1
staining in all images was in red. C:
quantification of the endocytosis of
FITC-albumin in PTC and MCDC un-
der different conditions. The cells
were treated with normal Ringer solu-
tion, bafilomycin A-1 (500 nM), glu-
conate-containing solution, or Bafilo-
mycin A-1 plus gluconate solution for
2 h at 37°C before the endocytosis
assays were performed. Bafilomycin
A-1 and gluconate treatments signifi-
cantly reduced the endocytosis of al-
bumin in WT cells. No additive inhib-
itory effect was detected by the double
treatments with bafilomycin A-1 plus
gluconate. In contrast, ClC-5 KO cells
were not sensitive to the same treat-
ments (#P  0.001 is the difference
between WT and KO cells under the
control conditions, n  15. *P 
0.001 is the difference between con-
trol condition and different treatments
in WT cells, n  15). Right: endocy-
tosis of albumin in MCDC measured
at 4 and 37°C. No difference in endo-
cytosis was found between WT and
KO MCDC. D: quantification of the
endocytosis of FITC-dextran in pri-
mary PTC under different conditions.
WT cells were sensitive to the bafilo-
mycin A-1 and gluconate treatments,
whereas KO cells were not (†P 
0.01, difference between WT and KO
cells under the control condition, n 
15. ‡P  0.01, difference between
control condition and different treat-
ments in WT cells, n  15).
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Lysates from MCDC from mouse kidneys were used as neg-
ative controls (Fig. 1D). The expression of APN in WT and KO
primary cells is comparable, which indicates the ratio of cells
expressing proximal tubule markers in both WT and KO
primary cells is the same.
Cultured cells from both WT and KO animals express the
proximal tubule marker megalin (Fig. 1E), verifying further
their proximal tubule origin (3, 5). Megalin expression in KO
cells is 24.2% of that of WT cells (shown in the bar graph in
Fig. 1E), which is similar to the difference in megalin expres-
sion between WT and KO proximal tubules. Lysates from
LLC-PK1 cells and proximal tubules were used as positive
controls, whereas lysates from MCDC and Cos-7 cells were
used as negative controls. The reduction of megalin expression
in KO compared with WT primary cultures is also evident from
the immunofluorescence data shown in Fig. 2.
Endocytosis of dextran in primary proximal tubular cells. To
determine that primary cells do indeed undergo endocytosis,
cells were treated either with dextran or albumin as markers of
fluid phase and receptor-mediated endocytosis, respectively
(15, 33, 38). An example of dextran-treated cells is shown in
Fig. 2. WT cells rapidly took up labeled dextran when cells
were treated with 5 mg/ml dextran for 1 min at 37°C, washed,
and allowed to warm for 15 min, whereas no label could be
detected in the KO cells during the same time period. To test
whether the endocytosis was completely abolished in KO cells,
the incubation time was increased to 5 min, the cells were
washed as before and allowed to warm for 30 min, and the
concentration of dextran was increased to 50 mg/ml. Under this
condition, label could be detected sporadically in the KO cells
but always in lower abundance than in WT cells. This verifies
that the primary cultures of proximal tubule cells are capable of
endocytosis in this experimental setting.
To more comprehensively understand endocytosis in proxi-
mal tubules, cultured cells were incubated with 10 mg/ml of
fluorescently labeled albumin or dextran for 15 min at 37°C,
then washed and stained with anti-ZO-1 antibody (red), and the
amount of uptake was quantified by measurement of fluores-
cence intensity normalized per cell. Shown in Fig. 3Aa, both
WT and KO primary proximal tubular cells take up significant
quantities of albumin (green), although the amount in KO cells
was visually much less than that in WT cells. Note that cells
cultured from the MCDC also take up albumin but there is no
apparent difference between WT and KO cells (Fig. 3Ab).
Figure 3, Ba and Bb, shows the images acquired from cells
exposed to albumin at 4°C as negative controls.
Quantification of albumin and dextran uptake in those cells
is presented in Fig. 3, C and D. WT primary proximal tubular
cells endocytose both albumin and dextran. KO primary prox-
imal tubule cells also take up both markers but at reduced
levels, 48 and 61% of WT, respectively, indicating that recep-
tor-mediated and fluid phase endocytosis is not completely
abolished in the KO cells. Note also that there is no difference
in endocytosis between WT and KO measured in MCDC.
To further explore the role of ClC-5 in endocytosis, cells
were treated with the vacuolar proton pump inhibiter Bafilo-
mycin A-1 (4) or Cl was replaced by gluconate (19), both for
2 h at 37°C and then endocytosis of albumin or dextran was
measured (Fig. 3C). Bafilomycin A-1 is expected to inhibit the
proton pump and thus endosomal acidification. Because glu-
conate is not permeable to most anion channels (including
Fig. 4. Bafilomycin A-1, gluconate, or bromide treatment reduces the endocytosis of
albumin and dextran in LLC-PK1 cells. The average intensity of fluorescent-labeled
markers per cell was quantified under different treatment conditions as described in
EXPERIMENTAL PROCEDURES. Control was done at 4°C. A: bafilomycin A-1 and
gluconate treatments inhibited the endocytosis of albumin in LLC-PK1 cells. See the
detailed protocol in EXPERIMENTAL PROCEDURES. B: inhibitory effects of bafilomycin
A-1 and gluconate treatments on the endocytosis of dextran in LLC-PK1 cells. C:
inhibitory effects of bromide and gluconate treatments on the endocytosis of albumin
in LLC-PK1 cells. Bromide inhibited endocytosis of albumin compared with the
normal control level, but the effect was not as great as that of gluconate.
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ClC-5) (13), replacing the Cl-containing solution with a glu-
conate-containing solution is expected to inhibit albumin en-
docytosis presumably due to the lack of Cl available in the
cytosol for ClC-5 to transport across the endosomal membrane.
In WT primary proximal tubular cells, uptake of both albumin
(Fig. 3C) and dextran (Fig. 3D) was significantly reduced by
bafilomycin A-1 treatment and gluconate replacement. The
effects of bafilomycin A-1 and gluconate were indistinguish-
able, which indicated that their effects were on the same
pathway. In contrast, in KO primary proximal tubular cells, the
same treatments did not significantly reduce endocytosis of
either albumin or dextran.
Endocytosis in LLC-PK1 cells. To further assess the role of
ClC-5 in the time course of endocytosis, we studied LLC-PK1
cells, which afforded us a large number of cells from an
established and well-studied cell line known to express ClC-5
(8, 13). LLC-PK1 cells also took up both albumin and dextran.
When Cl was replaced by gluconate or treated with Bafilo-
mycin A-1, endocytosis was reduced (Fig. 4, A and B). Bro-
mide (Br) is another anion that is not highly selective for
ClC-5 (8, 37). Figure 4C showed that replacement of Cl with
Br decreased endocytosis of albumin, although the effect of
Br was not as robust as gluconate.
ClC-5-independent endocytosis of albumin involves NHE3
in LLC-PK1 cells and primary proximal tubule cells. Because
48% of endocytosis of albumin is ClC-5 independent, we
explored the role of NHE3 in the residual endocytosis. Both in
vivo and in vitro studies showed that NHE3 blockade interferes
with apical receptor-mediated endocytosis of albumin (16, 18)
and that NHE3 is a source of endosomal acidification at an
intracellular vesicular compartment in different cell models (1,
11, 15, 30).
In WT primary cells, shown in Fig. 5A, albumin endocytosis
was reduced by 46% by the NHE3 inhibitor, S3226. Bafilo-
mycin A-1 treatment or Cl replacement by gluconate further
reduced endocytosis to 25% of the control level. In ClC-5 KO
primary cells, S3226 was still effective in decreasing endocy-
tosis to 56% of that in the untreated KO cells. In contrast to
WT cells, in the KO cells treatment with bafilomycin A-1 or
Cl replacement by gluconate did not reduce endocytosis
beyond that of S3226.
Similar results were obtained in LLC-PK1 cells, which
contain endogenous ClC-5. S3226 (1 M) reduced the endo-
cytosis of albumin to less than 50% of the control level (Fig.
5B). Likewise, when cells were treated with bafilomycin A-1 or
Cl was replaced by gluconate in the presence of S3226, there
Fig. 5. Quantification of endocytosis of FITC-albumin
shows an inhibitory effect of NHE3 blocker (S3226),
bafilomycin A-1, and gluconate in both primary and
LLC-PK1 cells. A: primary tubular cells. The WT and
KO primary cells were incubated with S3226-contain-
ing solution for 2 h, followed by the endocytosis assay
described in EXPERIMENTAL PROCEDURES. The treatment
with S3226 alone reduced the endocytosis of FITC-
albumin in WT cells. The double treatments with S3226
and bafilomycin A-1 or gluconate further inhibited the
uptake of FITC-albumin in these cells (*P  0.001 is
the difference between the control condition and S3226
treatment in WT cells, n  15). In contrast, in ClC-5
KO cells, the single treatment with S3226 had an
inhibitory effect, but the double treatments with S3226
and bafilomycin A-1 or gluconate failed to show an
additive effect (†P  0.001 is the difference between
WT and KO cells under the control condition, n  15.
‡P  0.001 is the difference between the control con-
dition and S3226 treatment in KO cells, n  15. #P 
0.01 is the difference between S3226 treatment and the
double treatments with bafilomycin A-1 or gluconate,
n  15). B: LLC-PK1 cells. S3226 greatly reduced the
albumin endocytosis, and the double treatments with
S3226 and bafilomycin A-1 or gluconate further inhib-
ited endocytosis. A similar finding was further verified
with experiments done at one time point with lower
concentrations of FITC-albumin (10 g/ml; data not
shown).
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was an additional 30% inhibitory effect. The total endocytosis
remaining after the double treatments was20% of the control
level. These data show that both the H-ATPase and NHE3
play roles in receptor-mediated endocytosis in WT primary
proximal tubular cells and LLC-PK1 cells, but only NHE3
contributes to endocytosis in the ClC-5 KO mouse cells.
Infection with adenovirus containing WT ClC-5 gene re-
stores endocytosis in KO primary proximal tubule cells. To test
whether the addition of normal ClC-5 to KO primary proximal
tubule cells could rescue endocytosis, we constructed an ade-
novirus (Ad) vector containing WT-ClC-5 gene. Figure 6A is a
Western blot showing that myc-ClC-5 protein expression was
present in WT and KO cells infected with the vector. The
uptake of albumin was not enhanced after infection of WT
cultures with Ad WT-ClC-5 vector. In contrast, there was a
dramatic increase in the uptake in the KO cells, restoring
endocytosis to normal levels. Colocalization between myc-
WT-ClC-5 and albumin could be seen in these virus-positive
cells, indicating its involvement in albumin containing vesicles
(Fig. 6B). Quantification of the average intensity of these
virus-positive WT and ClC-5 KO cells confirmed the micro-
scopic result (Fig. 6C). These data show that the KO cells
retain the machinery necessary for ClC-5 to support endocy-
tosis and that ClC-5 alone is sufficient to reconstitute albumin
endocytosis.
Functional studies of endocytosis of disease-causing mu-
tants of ClC-5. To gain insight into Dent’s disease causing
mutations in ClC-5, primary proximal tubule cells were in-
fected with Ad virus containing different mutant constructs
W22G, S520P, and R704X, each of which causes Dent’s
Fig. 6. Adenovirus infection rescued the endocytosis
of ClC-5 KO primary cells. A: Western blot analysis
using the myc antibody confirms the expression of
myc-ClC-5 in WT and ClC-5 KO primary cells. The
cells were infected with adenovirus for 48 h at multi-
plication of infection (MOI) of 250 before the cell
lysate was collected and Western blot analysis was
performed. B: confocal images showing the endocyto-
sis of FITC-albumin in WT and ClC-5 KO primary
proximal tubule cells infected with adenovirus contain-
ing the normal ClC-5 gene. Primary proximal tubule
cells were infected with adenovirus for 48 h, and then
the endocytosis assay was performed. Left: myc-ClC-5
in red. Middle: albumin-containing vesicles. Right:
overlay (bar 20 m). C: quantification of the endocy-
tosis of FITC-albumin in adenovirus-positive ClC-5
KO primary cells showing the restoration of endocyto-
sis (*P  0.001 is the difference between WT and KO
cells under the control condition without virus infec-
tion, n  15).
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disease. Protein expression was detected using immunostaining
(Fig. 7A) and confirmed by Western blot analysis (data not
shown). Figure 7A shows that WT and mutant ClC-5 are
expressed in both WT and ClC-5 KO primary proximal tubule
cells after infection. Importantly, even though protein was
expressed after infection of all the constructs, endocytosis of
albumin was restored in KO cells infected with Ad vectors
containing only WT ClC-5 but not the three ClC-5 mutants
(Fig. 7B).
Distribution of mutant ClC-5 detected by surface biotinyla-
tion in LLC-PK1. To study the disease mutants further, LLC-
PK1 cells were transfected with myc-ClC-5 constructs contain-
ing WT or the different mutations, and surface expression was
detected by surface biotinylation (Fig. 8). The percentage of
the surface protein compared with the total cell lysate was
calculated. The results showed that there was no significant
difference in the fraction of myc-WT-ClC-5 present at the cell
surface (8.2 	 2%) compared with the three mutants (myc-
Fig. 7. Mutant myc-ClC-5 fails to restore endocytosis in KO cells. A: confocal images confirming that myc-ClC-5 WT and mutants are expressed after adenovirus
infection in the WT and ClC-5 KO primary cells. ZO-1 (red) is used as the tight junction marker (bar 20 m). B: quantification of the endocytosis of
FITC-albumin in ClC-5 KO primary proximal tubule cells infected with different adenovirus containing myc-ClC-5 mutants showing the lack of rescuing effect
on endocytosis. The cells were infected with adenovirus containing different myc-ClC-5 mutants for 48 h, followed by the endocytosis assay (*P  0.001 is the
difference between WT and KO cells under the control condition, n  15. #P  0.001 is the difference between the KO cells with virus infections with WT
and mutant myc-ClC-5, n  15. NS, difference between WT cells and KO cells with virus infection with WT myc-ClC-5, n  15).
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W22G-ClC-5 5.8 	 1%, myc-S520P-ClC-5 3.7 	 1%, and
myc-R704X-ClC-5 5.4 	 2%).
Endocytosis function of mutant ClC-5 detected by surface-
biotinylated protein internalization assay in LLC-PK1. Endo-
cytosis of surface-biotinylated myc-ClC-5 was measured in
LLC-PK1 cells based on the protocol mentioned in EXPERIMEN-
TAL PROCEDURES. The results showed that 1.8% of myc-WT-
ClC-5 and 1.3% of W22G-ClC5 was internalized from the cell
surface (Fig. 9A, left). In contrast, almost none of myc-S520P-
ClC-5 or myc-R704X-ClC-5 was endocytosed from the sur-
face. The fraction of the surface WT and W22G-ClC-5 inter-
nalized was both 22%, whereas almost none of the other
mutants were internalized (Fig. 9A, right). The difference
between WT and S520P or WT and R704X was significant.
No significant difference could be detected in the magnitude
of endogenous endocytosis in LLC-PK1 cells transfected either
with WT-ClC-5, W22G-ClC-5, S520P-ClC-5, or R704X-
ClC-5 (Fig. 9B). This excludes the possibility that the different
levels of internalization of these mutants shown in Fig. 9A are
simply due to differences in the general rate of endocytosis
after transfection with mutant ClC-5. Thus the lack of inter-
nalization of S520P-ClC-5 or R704X-ClC-5 from the plasma
membrane is caused by trafficking problems specific to these
proteins.
DISCUSSION
It is currently believed that ClC-5 and the H-ATPase
cooperate to facilitate the internalization of various proteins
and small molecules from the renal proximal tubule with ClC-5
providing a Cl shunt to facilitate acidification by the proton
pump (28, 33, 38). Thus defects in ClC-5 function can impair
the transport of anions into the endosomes with elevated
gradient slowing down the rate of acidification. For example,
depletion of ClC-5 using antisense RNA in Caco-2 cells leads
to an increase of endosomal pH (32). In the ClC-5 KO mice it
was shown that acidification occurred at a significantly lower
rate than in WT endosomes (21). We show in this study, using
endocytosis as a read-out, that ClC-5 and the H-ATPase are
both critical components for endocytosis. However, in the KO
mice that lack ClC-5, endocytosis still takes place although at
a reduced rate. A key finding is that in the KO mouse proximal
tubule cells, endocytosis is insensitive to bafilomycin A-1 and
removal of Cl from the medium, whereas endocytosis in the
WT mice is sensitive to both. Relevant is that the inhibitory
effects of the two maneuvers are indistinguishable, suggesting
that they are critical in the same pathway or at the same stage
of endocytosis. The absence of sensitivity to both maneuvers in
KO cells points to the removal of the functional role of the
H-ATPase in endocytosis in the absence of ClC-5. Moreover,
the restoration of endocytic function in KO cells following
infection with an adenovirus containing normal myc-ClC-5
gene suggests that the KO cells retain the receptor-mediated
endocytic machinery but just need ClC-5 for it to function
properly. Megalin is the receptor in the proximal tubules
involved in the receptor-mediated endocytosis of albumin.
Christensen et al. (6) identified in their studies that loss of
ClC-5 resulted in defective trafficking of megalin and cubilin
in kidney proximal tubules, which leads to proteinuria. The fact
that blockade of the H-ATPase and chloride transport across
the endosomes subsequent to the defective function of ClC-5
leads to a reduction in endocytosis in both receptor-mediated
and fluid phase pathways indicated that a decrease of the
number of megalin receptors in ClC-5 KO primary cells was
not the only determinant factor.
Importantly, the data showed that the residual receptor-
mediated endocytosis in the KO mouse proximal tubule cells is
sensitive to the NHE3 blocker, S3226. This supports the role of
NHE3 in endocytosis that Gekle et al. (15, 17) identified. In
their in vitro studies, NHE3 deficiency dramatically reduced
endocytosis, and the inhibition of NHE3 alkalinized the early
endosomes. In addition, their in vivo data demonstrated that
S3226 reduced [14C] cytochrome reabsorption from early prox-
imal tubules, and NHE3 KO mice presented with proteinuria
(18). Our data further confirmed the contribution of Na-H
Fig. 8. Surface expression of WT and ClC-5 mutants in transfected LLC-PK1 cells. Surface biotinylation experiment in LLC-PK1 cells transfected with each
of the 4 constructs showing their surface expression. LLC-PK1 cells were surface labeled with NHS-S-S-biotin, and then the surface protein was collected from
Neutravidin beads after pull-down from the biotinylated protein pool. Left: Western blot analysis of both cell lysate and surface fraction detected by
anti-myc-antibody. Right: quantification. All of these myc-ClC-5 proteins were expressed and trafficked onto the cell surface. The quantification of the expression
of different mutants of ClC-5 showed no significant difference compared with WT-ClC-5 (data not shown).
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exchange to endocytosis, and indirectly to the acidification of
the early endosomal compartment. In WT mice, whether
NHE3, ClC-5, and H-ATPase are all located in the same
population of vesicles is still not known. Clearly, one possi-
bility is that they colocalize in the same vesicles, but their roles
vary during different stages of endocytosis. It is also possible
that their functions are redundant during some phases of
endocytosis. Another possibility is that they are present in a
different subpopulation of vesicles where they discriminate
among the different endocytic cargos.
Mutations in ClC-5 are known to cause Dent’s disease (25,
26). In this study, we focused on three human ClC-5 mutants
(W22G, S520P, R704X) to understand further how these mu-
tants may cause disease. We chose these three mutants because
the Cl transport characteristics were studied extensively in
patch-clamping experiments in X. laevis oocytes. The results of
the published studies showed that W22G-ClC-5 and R704X-
ClC-5 do not produce any Cl currents across the oocyte
plasma membrane, whereas S520P-ClC-5 generated a reduced
current. All of the mutants were expressed abundantly in ClC-5
KO primary proximal tubular cells infected with adenoviral
vectors containing the mutant genes. However, none could
efficiently rescue endocytosis to normal values. This is cer-
tainly expected for W22G-ClC-5 and R704X-ClC-5 mutants,
which do not produce any currents in X. laevis oocytes, but
unexpected for the S520P-ClC-5 mutant, which still conducts
some Cl in X. laevis oocytes. Also, our previous study
showed the importance of the COOH terminus of ClC-5 in the
endocytic machinery by interaction with other protein com-
plexes, e.g., cofilin (23). Based on this, R704X-ClC-5 with
missing COOH terminus would certainly be predicted to have
defective function.
To determine the magnitude of the static pool of ClC-5 that
resides at the apical membrane, WT and mutant ClC-5 were
transfected into LLC-PK1 cells. These cells were used because
they allowed for sufficient material for the biochemical assays.
Fig. 9. Defective endocytosis of the
mutants in transfected LLC-PK1
cells. A: endocytic fraction of myc-
ClC-5 among the total lysate and the
surface pool was assessed by per-
forming the internalization assay of
surface-biotinylated protein in LLC-
PK1 cells transfected with different
myc-ClC-5 constructs. Approximately
1.2–1.8% of WT and W22G-ClC-5
(left) of total cellular ClC-5 were inter-
nalized from the cell surface. How-
ever, none of myc-S520P-ClC-5 and
myc-R704X-ClC-5 was internalized
into the vesicles from the cell surface
(*P  0.05 is the difference between
WT and S520P or R704X, n  8);
22% of the surface pool of WT and
W22G-ClC-5 (right) but no S520P and
R704X-ClC-5 were internalized. B:
magnitude of endocytosis in LLC-PK1
cells transfected with different myc-
ClC-5 constructs was measured at 6
time points. At each time point, no
significant difference could be detected
between the endogenous internaliza-
tion rate and the rate after transfection
with any of the constructs.
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Surface biotinylation experiments in LLC-PK1 cells trans-
fected with ClC-5 confirmed that only a small amount of both
WT and mutant ClC-5 is at the plasma membrane.
We also tested the mutants in an endocytosis assay where
internalization of surface-biotinylated protein was measured in
LLC-PK1 cells transfected with WT and mutant ClC-5 con-
structs. LLC-PK1 cells have endogenous ClC-5 and undergo
normal endocytosis. The additional WT or mutant ClC-5 pro-
tein from transfection resulted in higher expression levels than
endogenous ClC-5 (data not shown). However, the added
expression of either WT or mutant ClC-5 to that already
expressed in LLC-PK1 cells had no effect on endocytosis of
albumin. This excludes the possibility of a dominant-negative
effect from the mutant ClC-5 protein on endogenous ClC-5
function. The results showed that 1.8% of myc-WT-ClC-5
compared with the total lysate was internalized from the
plasma membrane into endosomes, and 1.3% of the mutant
W22G. About 4–8% of the total WT or mutant myc-ClC-5 is
at the apical surface and from this surface protein pool; 22% of
both WT and W22G-ClC-5 was internalized. In contrast, al-
most none of myc-S520P-ClC-5 and myc-R704X-ClC-5 was
internalized into endosomes from the surface. Thus our data
show that disorders in endocytosis can be caused either by a
lack of Cl currents as has been suggested in the literature or
a lack of targeting of ClC-5 to the endosomes. This is partic-
ularly evident with the S520P mutant that retains the ability to
go to the plasma membrane and function as a Cl transporter
as shown in the X. laevis oocytes experiments (26) but does not
correct defective endocytosis when infected into mouse pri-
mary cultures. This is surprising because if there is still some
residual function as suggested, in the oocyte studies the over-
expression of this mutant in mouse KO cells would be expected
to restore at least partial function. The observation that this
mutant does not restore partial function suggests that the likely
cause of defective function of this mutant is inefficient traf-
ficking to the endosome.
In conclusion, ClC-5 is essential for the reabsorption of low
molecular mass proteins and other solutes in the proximal
tubules of kidneys. Our work established for the first time
primary proximal tubule cells from ClC-5 KO mice kidneys
and demonstrated defective endocytosis in the KO cells that
could be rescued by infection with normal ClC-5. We showed
that ClC-5 plays an important role in both receptor- and
nonreceptor-mediated endocytic pathways. The proper func-
tioning of the H-ATPase and ClC-5 is essential for normal
levels of endocytosis in proximal tubule cells, which was
confirmed by the fact that no further inhibitory effect could be
detected from bafilomycin A-1 or gluconate treatment in ClC-5
KO primary cells. NHE3 functions in endocytosis presumably
in a residual population of the vesicles. Three human mutants
W22G, S520P, and R704X are all present at the cell surface,
but S520P and R704X are not capable of efficient targeting to
endosomes. As a result, the disease symptoms in patients with
these mutations are likely derived either from defective protein
trafficking and targeting to endosomes or lack of Cl channel
activity or both.
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